ASX · CSL.AX
CSL Limited
A$200.73+A$3.23 (+1.64%)
CSL Limited’s quoted price sits in the upper half of its reported 52-week range, 0.69% below the high.
Loading market information…
ASX · AHC.AX · AUD
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 04:43 AM UTC. Cached market data; not a live quote.
One-year closing-price history · AUD. Historical prices are not a forecast.
Austco Healthcare Limited’s quoted price sits in the lower half of its reported 52-week range, 37.08% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
Austco Healthcare Limited’s forward annual dividend is A$0.00 per share, paid semi-annual. The forward yield is 1.25% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Austco Healthcare Limited’s next earnings report is currently expected on Feb 25, 2027. The reporting date and estimates may change.
Upcoming dates and analyst estimates may change. Fiscal quarters follow Austco Healthcare Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Austco Healthcare Limited, through its subsidiaries, operates as a global entity focused on the development, production, and comprehensive servicing of advanced healthcare and electronic communication systems. The company's market reach extends across Australia, New Zealand, Asia, Europe, and North America. A significant product in its portfolio is Tacera, an internet protocol (IP) based nurse call solution specifically engineered for both hospitals and aged care facilities. Originally founded in 1986, the company adopted its current name, Austco Healthcare Limited, in November 2020, having previously been known as Azure Healthcare Limited. Its corporate headquarters are located in Port Melbourne, Australia.
Latest available per-share figures in AUD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 10:34 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
| A$20.54M |
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
A$200.73+A$3.23 (+1.64%)
CSL Limited’s quoted price sits in the upper half of its reported 52-week range, 0.69% below the high.
A$2.73+A$0.01 (+0.37%)
Sigma Healthcare Limited’s quoted price sits in the lower half of its reported 52-week range, 14.69% below the high.
A$196.20-A$0.89 (-0.45%)
Pro Medicus Limited’s quoted price sits in the upper half of its reported 52-week range, 28.09% below the high.
A$55.60+A$0.68 (+1.24%)
Ramsay Health Care Limited’s quoted price sits in the upper half of its reported 52-week range, 0.89% below the high.
A$19.57+A$0.50 (+2.62%)
Sonic Healthcare Limited’s quoted price sits in the lower half of its reported 52-week range, 19.37% below the high.
A$143.64+A$1.44 (+1.01%)
Cochlear Limited’s quoted price sits in the lower half of its reported 52-week range, 50.67% below the high.
$0.15$0.00 (0.0%)
Oneview Healthcare PLC’s quoted price sits in the lower half of its reported 52-week range, 6.25% below the high.
A$0.11-A$0.01 (-4.35%)
Alcidion Group Limited’s quoted price sits in the lower half of its reported 52-week range, 24.14% below the high.
